ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

Broder Hopes To Help “Fundable: Centers, Stops Short Of Promising Compliance With All IOM Points

May 5, 1989

Funding opportunities listed.

February 13, 2004

Can NCI Fund 4-Year Grants With 2-Year Stimulus Funds?

March 6, 2009

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992